International
US: Department of Health recommends moving cannabis to Schedule III of the Controlled Substances Act
TheDepartment of Health and Human Services (HHS), a federal agency of the United States of America, recommended to the DEA — Drug Enforcement Administrationthat cannabis be moved from Schedule I to Schedule III of the Controlled Substances Act. This was confirmed by Bloomberg News, who had access to the letter, dated yesterday, August 29, sent by the HHS Health representative, Rachel Levine, to Anne Milgram, administrator of the DEA, who will have the final say.
The recommendation comes after the HHS completed a scientific review on cannabis, under a directive from US President Joe Biden. A DEA spokesperson confirmed to Bloomberg News that the DEA has received the letter and that it must now begin its own review to decide whether to approve or reject the cannabis reclassification.
This step represents a breakthrough in cannabis policy in the US, as it reveals that the main health agency no longer considers cannabis as “a drug with a high potential for abuse and without any medicinal value”, as referred to in Table I of the Law of Controlled Substances, which also include heroin, ecstasy or LSD. Schedule III substances, such as ketamine, are considered “less dangerous” and can be obtained legally with a prescription.
The HHS recommendation is not binding, leaving the DEA with the final decision, but it is believed that with the positive trend in the US political scenario, the reclassification may happen. Joe Biden would add one more achievement before next year's election, and the taxes that cannabis companies pay could drop significantly. Cannabis advocates also say the reclassification would be a recognition by the federal government that cannabis has legitimate uses and would be a step on the road to greater acceptance and availability of plant-based products. Yesterday and today, the shares of several companies in the cannabis sector rose considerably, according to the report of Bloomberg.
____________________________________________________________________________________________________
[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]____________________________________________________________________________________________________
What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!
With a degree in Journalism from the University of Coimbra, Laura Ramos has a postgraduate degree in Photography and has been a Journalist since 1998. Winner of the Business of Cannabis Awards in the category "Journalist of the Year 2024", Laura was a correspondent for Jornal de Notícias in Rome, Italy, and Press Officer in the Office of the Minister of Education of the 21st Portuguese Government. She has an international certification in Permaculture (PDC) and created the street-art photography archive “Say What? Lisbon” @saywhatlisbon. Co-founder and Editor of CannaReporter® and coordinator of PTMC - Portugal Medical Cannabis, Laura directed the documentary “Pacientes” and was part of the steering group of the first Postgraduate Course in GxP's for Medicinal Cannabis in Portugal, in partnership with the Military Laboratory and the Faculty of Pharmacy of the University of Lisbon.
Thailand has found a solution where European countries still see a problem.
Reading Time: 13 minutes On my second trip to Thailand, I was once again pleasantly surprised. After visiting several...
The Royal Thai Embassy in Tokyo promotes "Adapting International Hemp to Japan's New Regulations"
Reading Time: 3 minutes The International Business Meeting “Adapting the International Market...” will take place tomorrow, November 13, 2025.
Portugal: Infarmed updates lists and removes licenses from two more medicinal cannabis companies.
Reading Time: 2 minutes. Infarmed has updated the public list of entities licensed for activities with medicinal cannabis in Portugal. The...
Portocanna strengthens its Hexacan portfolio with a new sublingual solution containing 20% THC.
Reading Time: 2 minutes. The Portuguese company Portocanna announced the launch of Hexacan® Hexa 01 Cannabis Oil Extract THC 20%,...
Cypress Hill confirmed for Rock in Rio Lisboa 2026
Reading Time: 2 minutes. The legendary American band Cypress Hill, whose hits "Insane in the Brain" and "Hits from the Bong"...
USA: Green Thumb Industries workers secure collective agreement after 45-day strike.
Reading Time: < 1 minute Workers at Green Thumb Industries, one of the largest multi-state cannabis companies in the United States...
Switzerland: Pacrim takes control of Medropharm and prepares for a new phase of expansion in medicinal cannabis.
Reading Time: 2 minutes. Pacrim has acquired two-thirds of the Swiss company Medropharm, thus gaining control of the company and its operations.
South Africa: Researchers discover rare phenolic compounds in cannabis leaves.
Reading Time: 4 minutes. Researchers at Stellenbosch University in South Africa have discovered that flavoalkaloids are produced in the leaves of the plant...
Covilhã – Dismantling of two cannabis greenhouses
Reading Time: < 1 minute The Castelo Branco Territorial Command, through the Criminal Investigation Unit (NIC) of Covilhã, in...
Tokyo will host the Japan International Hemp Expo on November 14th and 15th, 2025.
Reading Time: 4 minutes. For the first time since the legal reform, Japan opens its doors to the global hemp industry...
